Synopsis
0
USDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Enoxolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Enoxolone, including repackagers and relabelers. The FDA regulates Enoxolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Enoxolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Enoxolone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Enoxolone supplier is an individual or a company that provides Enoxolone active pharmaceutical ingredient (API) or Enoxolone finished formulations upon request. The Enoxolone suppliers may include Enoxolone API manufacturers, exporters, distributors and traders.
click here to find a list of Enoxolone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Enoxolone Drug Master File in Japan (Enoxolone JDMF) empowers Enoxolone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Enoxolone JDMF during the approval evaluation for pharmaceutical products. At the time of Enoxolone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Enoxolone suppliers with JDMF on PharmaCompass.
A Enoxolone CEP of the European Pharmacopoeia monograph is often referred to as a Enoxolone Certificate of Suitability (COS). The purpose of a Enoxolone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Enoxolone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Enoxolone to their clients by showing that a Enoxolone CEP has been issued for it. The manufacturer submits a Enoxolone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Enoxolone CEP holder for the record. Additionally, the data presented in the Enoxolone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Enoxolone DMF.
A Enoxolone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Enoxolone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Enoxolone suppliers with CEP (COS) on PharmaCompass.
A Enoxolone written confirmation (Enoxolone WC) is an official document issued by a regulatory agency to a Enoxolone manufacturer, verifying that the manufacturing facility of a Enoxolone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Enoxolone APIs or Enoxolone finished pharmaceutical products to another nation, regulatory agencies frequently require a Enoxolone WC (written confirmation) as part of the regulatory process.
click here to find a list of Enoxolone suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Enoxolone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Enoxolone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Enoxolone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Enoxolone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Enoxolone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Enoxolone suppliers with NDC on PharmaCompass.
Enoxolone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Enoxolone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Enoxolone GMP manufacturer or Enoxolone GMP API supplier for your needs.
A Enoxolone CoA (Certificate of Analysis) is a formal document that attests to Enoxolone's compliance with Enoxolone specifications and serves as a tool for batch-level quality control.
Enoxolone CoA mostly includes findings from lab analyses of a specific batch. For each Enoxolone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Enoxolone may be tested according to a variety of international standards, such as European Pharmacopoeia (Enoxolone EP), Enoxolone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Enoxolone USP).
LOOKING FOR A SUPPLIER?
